210 related articles for article (PubMed ID: 24927959)
1. Control of Japanese encephalitis in Asia: the time is now.
Hills S; Martin R; Marfin A; Fischer M
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):901-4. PubMed ID: 24927959
[TBL] [Abstract][Full Text] [Related]
2. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Fischer M; Lindsey N; Staples JE; Hills S;
MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
[TBL] [Abstract][Full Text] [Related]
3. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
4. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
Hegde NR; Gore MM
Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
[TBL] [Abstract][Full Text] [Related]
5. Japanese Encephalitis Surveillance and Immunization - Asia and Western Pacific Regions, 2016.
Heffelfinger JD; Li X; Batmunkh N; Grabovac V; Diorditsa S; Liyanage JB; Pattamadilok S; Bahl S; Vannice KS; Hyde TB; Chu SY; Fox KK; Hills SL; Marfin AA
MMWR Morb Mortal Wkly Rep; 2017 Jun; 66(22):579-583. PubMed ID: 28594790
[TBL] [Abstract][Full Text] [Related]
6. Product review on the JE vaccine IXIARO.
Firbas C; Jilma B
Hum Vaccin Immunother; 2015; 11(2):411-20. PubMed ID: 25621812
[TBL] [Abstract][Full Text] [Related]
7. Japanese encephalitis surveillance and immunization--Asia and the Western Pacific, 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):658-62. PubMed ID: 23965828
[TBL] [Abstract][Full Text] [Related]
8. Japanese encephalitis: the virus and vaccines.
Yun SI; Lee YM
Hum Vaccin Immunother; 2014; 10(2):263-79. PubMed ID: 24161909
[TBL] [Abstract][Full Text] [Related]
9. Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV).
Appaiahgari MB; Vrati S
Expert Opin Biol Ther; 2012 Sep; 12(9):1251-63. PubMed ID: 22775524
[TBL] [Abstract][Full Text] [Related]
10. Development of a recombinant vaccine against Japanese encephalitis.
Kaur R; Vrati S
J Neurovirol; 2003 Aug; 9(4):421-31. PubMed ID: 12907387
[TBL] [Abstract][Full Text] [Related]
11. The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen.
Moore SM
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009385. PubMed ID: 34644296
[TBL] [Abstract][Full Text] [Related]
12. Current use and development of vaccines for Japanese encephalitis.
Beasley DW; Lewthwaite P; Solomon T
Expert Opin Biol Ther; 2008 Jan; 8(1):95-106. PubMed ID: 18081539
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region.
Dubischar KL; Kadlecek V; Sablan JB; Borja-Tabora CF; Gatchalian S; Eder-Lingelbach S; Kiermayr S; Spruth M; Westritschnig K
Pediatr Infect Dis J; 2017 Sep; 36(9):898-904. PubMed ID: 28430748
[TBL] [Abstract][Full Text] [Related]
14. Japanese Encephalitis Vaccine.
Mileno MD
R I Med J (2013); 2020 Aug; 103(6):49-50. PubMed ID: 32752568
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis revisited.
Diagana M; Preux PM; Dumas M
J Neurol Sci; 2007 Nov; 262(1-2):165-70. PubMed ID: 17643451
[TBL] [Abstract][Full Text] [Related]
16. Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
Capeding MR; Alberto ER; Bouckenooghe A; Laot TM; Chansinghakul D; Monfredo C; Machabert T; Feroldi E
J Infect Dis; 2018 Jan; 217(4):567-571. PubMed ID: 29325161
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
[TBL] [Abstract][Full Text] [Related]
18. Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis control.
Murhekar MV; Oak C; Ranjan P; Kanagasabai K; Shinde S; Pandey AK; Mittal M; Gore M; Mehendale SM
Indian J Med Res; 2017 Jan; 145(1):63-69. PubMed ID: 28574016
[TBL] [Abstract][Full Text] [Related]
19. WHO working group on the quality, safety and efficacy of japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21-23 February 2012.
Trent DW; Minor P; Jivapaisarnpong T; Shin J;
Biologicals; 2013 Nov; 41(6):450-7. PubMed ID: 23891495
[TBL] [Abstract][Full Text] [Related]
20. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
Appaiahgari MB; Vrati S
Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
